Archive

All Posts

Replimune wins on the third try; Xspray's cash won't last the year

Regulatory

Aug 10, 2026

Replimune wins on the third try; Xspray's cash won't last the year

Plus: Korean pharma's push into Latin America, and whether whole brain emulation is real science

Admin BioKnow

Alnylam falls 29% on a billion-dollar quarter

Funding

Aug 5, 2026

Alnylam falls 29% on a billion-dollar quarter

Plus: Ratio raises $70M to scale radiopharma manufacturing, and Obsidian closes the Galera merger with $350M behind it

Admin BioKnow

A 100% tariff on generics, and $800M more for AI drug discovery

Regulatory

Jul 27, 2026

A 100% tariff on generics, and $800M more for AI drug discovery

Plus: an FDA warning letter over informed consent, and Nona's antibody platform heads to Vienna

Admin BioKnow

Jul 19, 2026

Your Weekly Biotech Brief

20 July 2026

Adan Kovinich

Jul 12, 2026

Your Weekly Biotech Brief

13 July 2026

Adan Kovinich

Jul 6, 2026

Takeda Enters $600M AI-Driven Partnership with Insilico Medicine

6 July 2026

Admin BioKnow

Jun 29, 2026

Genflow Biosciences to Unveil Canine Longevity Data

29 June 2026

Admin BioKnow

Jun 22, 2026

USTR Launches Section 301 Investigation into German Drug Pricing

22 June 2026

Admin BioKnow

Jun 15, 2026

Novo Nordisk reports data breach of Clinical Trials Data

15 June 2026

Admin BioKnow

Archive

Replimune wins on the third try; Xspray's cash won't last the year

Alnylam falls 29% on a billion-dollar quarter

A 100% tariff on generics, and $800M more for AI drug discovery

Your Weekly Biotech Brief

Your Weekly Biotech Brief

Takeda Enters $600M AI-Driven Partnership with Insilico Medicine

Genflow Biosciences to Unveil Canine Longevity Data

USTR Launches Section 301 Investigation into German Drug Pricing

Novo Nordisk reports data breach of Clinical Trials Data

Inside Biotech with BioKnow